Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?


Manage episode 233865093 series 2394758
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN

Check out more of our content here:

1426 episodes available. A new episode about every 0 hours averaging 27 mins duration .